A multicentre, placebo controlled, double-blind study for evaluation of safety and efficacy of preseasonal specific immunotherapy with an allergoid preparation of an extract of a 6 grass pollen mixture in patients with clinically relevant grass pollen sensitivity.

Trial Profile

A multicentre, placebo controlled, double-blind study for evaluation of safety and efficacy of preseasonal specific immunotherapy with an allergoid preparation of an extract of a 6 grass pollen mixture in patients with clinically relevant grass pollen sensitivity.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jul 2014

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Grass pollen hypersensitivity; Rhinoconjunctivitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Allergopharma
  • Most Recent Events

    • 14 Feb 2008 The expected completion date for this trial is now 1 Aug 2006.
    • 30 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top